Alzheimer Disease

>

Latest News

From the relationship between social media and self-diagnosis to the FDA approval of the first treatment for agitation associated with Alzheimer disease dementia, here are highlights from the week in Psychiatric Times.
The Week in Review: May 8-12

May 13th 2023

From the relationship between social media and self-diagnosis to the FDA approval of the first treatment for agitation associated with Alzheimer disease dementia, here are highlights from the week in Psychiatric Times.

FDA approved
FDA Approves First Treatment for Agitation Associated With Alzheimer Disease Dementia

May 10th 2023

From eating disorders in entertainment to early intervention for schizophrenia, here are highlights from the week in Psychiatric Times.
The Week in Review: April 17-21

April 22nd 2023

If approved, the drug will be the first FDA-approved treatment for agitation associated with Alzheimer dementia in the United States.
Progress Made Toward the Approval of Treatment of Agitation Associated With Alzheimer Dementia

April 17th 2023

The experts weighed in on a wide variety of psychiatric issues for the March 2023 issue of Psychiatric Times.
From the Pages of Psychiatric Times: March 2023

March 31st 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.